CGC

Canopy Growth Corp. 10-Q Summary: Q1 Fiscal 2027

Business Context and Reporting Period

This summary covers Canopy Growth Corporation's (CGC) unaudited financial results for the quarterly period ended June 30, 2026 (Q1 Fiscal 2027). CGC is a global cannabis producer and consumer packaged goods company operating primarily in Canada, Europe, and Australia, with a non-controlling interest in Canopy USA, LLC, which holds U.S. cannabis assets. The company reports in Canadian dollars (CAD).

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net revenue increased 13% year-over-year, driven by growth in Canadian medical cannabis (+22%) and adult-use (+10%), as well as Storz & Bickel vaporizer sales (+6%). The acquisition of MTL Cannabis Corp. contributed to flower sales growth.
• Profitability Improvement: Net loss narrowed significantly by 68% to $14.6 million. This improvement was primarily due to a $29.3 million swing in "Other income (expense), net," which turned from a $21.9 million expense in Q1 2025 to a $7.4 million gain in Q1 2026.
• Non-GAAP Fair Value Gains: The "Other income" gain was largely driven by a $16.2 million non-cash fair value increase in Canopy USA-related assets (specifically the Canopy USA LPs equity method investment), offsetting a $0.5 million decrease in the fair value of Acreage and Wana debt receivables.
• Margin Expansion: Consolidated gross margin percentage improved by 200 basis points to 27%. The Storz & Bickel segment saw a significant margin jump to 48% (from 29%) due to cost rationalization and a U.S. tariff refund. Cannabis segment margins declined slightly to 22% due to a reduction in Veterans Affairs Canada reimbursement rates and inventory step-up costs from the MTL acquisition.
• Operating Expenses: SG&A expenses rose 6% to $40.2 million, largely due to the MTL acquisition, partially offset by headcount reductions. Share-based compensation increased to $1.4 million from a reversal of $0.1 million in the prior year.

Guidance, Outlook, Risks, and Unusual Items

• Debt Restructuring & Default Risk: Acreage Holdings, a key U.S. asset held by Canopy USA, is currently in default under its credit agreement (Third ARCA). Canopy Growth holds a significant portion of the debt ($185.9 million principal) but ranks behind a third-party lender. A forbearance agreement is in place until January 31, 2027. There is a risk that if Acreage cannot satisfy obligations, Canopy Growth could lose its investment.
• Internal Controls: The company disclosed that its disclosure controls and procedures were not effective as of June 30, 2026, due to a material weakness in internal control over financial reporting related to the classification of equity-linked instruments. A remediation plan is underway.
• Legal Proceedings: The company is subject to an ongoing SEC investigation regarding the BioSteel Canada revenue recognition review. Additionally, a putative class action lawsuit (Dziedziejko) was certified in December 2025 regarding alleged misrepresentations between 2021 and 2023.
• Capital Resources: CGC maintains a strong liquidity position with $336.6 million in cash. It has an active At-The-Market (ATM) equity program with approximately $102 million remaining capacity as of August 2026. No shares were sold under the ATM program during Q1 2026.
• Unusual Items: The financial results include significant non-cash fair value adjustments related to Canopy USA investments, which are highly sensitive to the probability of U.S. cannabis legalization and the performance of underlying assets like Wana and Jetty.

Investor Verification Checklist

• Acreage Default Status: Verify the current status of the Acreage forbearance agreement and the likelihood of repayment for the $185.9 million debt held by Canopy Growth.
• Internal Control Remediation: Monitor progress on the remediation of the material weakness regarding equity-linked instrument classification to ensure future financial reporting reliability.
• Canopy USA Valuation: Assess the sustainability of the $16.2 million fair value gain on Canopy USA LPs, given its dependence on U.S. regulatory changes and the performance of unconsolidated U.S. assets.
• SEC Investigation: Track developments in the SEC investigation concerning the BioSteel Canada revenue recognition review for potential fines or restatements.
• Cash Burn Rate: Review the trend in operating cash flow, which remains negative ($25.0 million outflow), to ensure the $336.6 million cash balance is sufficient to fund operations and debt service without immediate dilution.